Brief: Evoke Pharma Announces Issuance Of New U.S. Patent For Gimoti With Extended Exclusivity To Late 2038
06/08/2025 11:42
Aug 6 (Reuters) - Evoke Pharma Inc EVOK.O: EVOKE PHARMA ANNOUNCES ISSUANCE OF NEW U.S. PATENT FOR GIMOTI WITH EXTENDED EXCLUSIVITY TO LATE 2038 EVOKE PHARMA INC - PATENT TERM EXTENDED TO NOVEMBER 2038 FOR GIMOTI Source text: ID:nGNXX9d6H Further company coverage: EVOK.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary